Alan Sanders
Concepts (310)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Schizophrenia | 52 | 2022 | 507 | 5.650 |
Why?
| Genome-Wide Association Study | 44 | 2022 | 1530 | 3.600 |
Why?
| Homosexuality, Male | 7 | 2021 | 258 | 2.590 |
Why?
| Heterosexuality | 4 | 2021 | 20 | 1.910 |
Why?
| Polymorphism, Single Nucleotide | 40 | 2022 | 2338 | 1.810 |
Why?
| Gender Identity | 2 | 2021 | 46 | 1.690 |
Why?
| Genetic Linkage | 18 | 2021 | 646 | 1.520 |
Why?
| Genetic Predisposition to Disease | 35 | 2022 | 2227 | 1.440 |
Why?
| Mental Disorders | 9 | 2021 | 379 | 1.320 |
Why?
| Genome, Human | 12 | 2021 | 752 | 0.990 |
Why?
| Genetic Variation | 12 | 2018 | 1361 | 0.830 |
Why?
| Depressive Disorder, Major | 6 | 2021 | 138 | 0.790 |
Why?
| Bipolar Disorder | 14 | 2021 | 382 | 0.740 |
Why?
| Chromosomes, Human, Pair 8 | 3 | 2014 | 93 | 0.710 |
Why?
| Sequence Analysis, RNA | 3 | 2018 | 200 | 0.680 |
Why?
| General Practitioners | 1 | 2016 | 8 | 0.670 |
Why?
| Transcriptome | 4 | 2018 | 516 | 0.670 |
Why?
| DNA Copy Number Variations | 9 | 2019 | 177 | 0.650 |
Why?
| Genotype | 22 | 2019 | 1856 | 0.630 |
Why?
| Humans | 92 | 2022 | 83447 | 0.610 |
Why?
| Chromosome Mapping | 19 | 2015 | 1102 | 0.600 |
Why?
| Male | 50 | 2021 | 41899 | 0.600 |
Why?
| Gene Expression Regulation | 7 | 2018 | 1941 | 0.570 |
Why?
| Chromosomes, Human, X | 1 | 2014 | 55 | 0.560 |
Why?
| Patient Participation | 1 | 2016 | 192 | 0.560 |
Why?
| Family | 3 | 2009 | 311 | 0.560 |
Why?
| Sexual Behavior | 3 | 2021 | 276 | 0.550 |
Why?
| Referral and Consultation | 1 | 2016 | 324 | 0.520 |
Why?
| Induced Pluripotent Stem Cells | 3 | 2020 | 89 | 0.520 |
Why?
| Communication | 1 | 2016 | 406 | 0.500 |
Why?
| Chromosomes, Human, Pair 6 | 6 | 2009 | 133 | 0.470 |
Why?
| Parity | 1 | 2012 | 97 | 0.470 |
Why?
| Phenotype | 10 | 2021 | 2295 | 0.470 |
Why?
| Receptors, Serotonin | 2 | 2002 | 60 | 0.470 |
Why?
| Gene Expression Profiling | 3 | 2017 | 1367 | 0.470 |
Why?
| Fertility | 1 | 2012 | 94 | 0.470 |
Why?
| Alleles | 14 | 2022 | 1116 | 0.460 |
Why?
| Chromatin | 3 | 2020 | 344 | 0.460 |
Why?
| Siblings | 3 | 2021 | 112 | 0.460 |
Why?
| Female | 46 | 2021 | 44784 | 0.450 |
Why?
| Mothers | 1 | 2012 | 131 | 0.440 |
Why?
| Linkage Disequilibrium | 13 | 2016 | 482 | 0.440 |
Why?
| Quantitative Trait Loci | 6 | 2020 | 557 | 0.440 |
Why?
| Decision Making | 1 | 2016 | 618 | 0.430 |
Why?
| Genetic Loci | 4 | 2017 | 238 | 0.430 |
Why?
| Haplotypes | 7 | 2008 | 643 | 0.430 |
Why?
| Case-Control Studies | 12 | 2018 | 1825 | 0.430 |
Why?
| Genetic Markers | 10 | 2016 | 493 | 0.400 |
Why?
| Psychotic Disorders | 4 | 2021 | 171 | 0.400 |
Why?
| Catechol O-Methyltransferase | 2 | 2008 | 61 | 0.370 |
Why?
| Chromosomes, Human, Pair 22 | 2 | 2005 | 48 | 0.370 |
Why?
| Adult | 23 | 2018 | 25995 | 0.350 |
Why?
| Internet | 1 | 2010 | 321 | 0.340 |
Why?
| Lod Score | 9 | 2021 | 162 | 0.340 |
Why?
| Genetics, Behavioral | 2 | 2004 | 24 | 0.330 |
Why?
| Body Height | 3 | 2013 | 109 | 0.330 |
Why?
| Pedigree | 15 | 2012 | 1002 | 0.330 |
Why?
| Brain | 6 | 2020 | 2160 | 0.320 |
Why?
| Sequence Deletion | 2 | 2019 | 213 | 0.300 |
Why?
| Body Mass Index | 4 | 2015 | 784 | 0.300 |
Why?
| Multifactorial Inheritance | 3 | 2016 | 127 | 0.290 |
Why?
| Cell Adhesion Molecules | 1 | 2005 | 166 | 0.280 |
Why?
| Base Sequence | 9 | 2017 | 2430 | 0.280 |
Why?
| Gene Frequency | 10 | 2014 | 669 | 0.270 |
Why?
| Gene Regulatory Networks | 2 | 2018 | 282 | 0.270 |
Why?
| Phosphoproteins | 1 | 2005 | 271 | 0.260 |
Why?
| Psychopharmacology | 1 | 2002 | 26 | 0.250 |
Why?
| Middle Aged | 15 | 2018 | 25596 | 0.250 |
Why?
| Schizophrenic Psychology | 2 | 2012 | 129 | 0.240 |
Why?
| Chromosomes, Human, Pair 13 | 3 | 2017 | 54 | 0.240 |
Why?
| Chromosomes, Human, Pair 18 | 6 | 1999 | 45 | 0.240 |
Why?
| Nicotine | 2 | 2021 | 169 | 0.230 |
Why?
| Biological Evolution | 1 | 2009 | 902 | 0.220 |
Why?
| Sex Characteristics | 2 | 2021 | 309 | 0.220 |
Why?
| Chromosomes, Human, Pair 15 | 3 | 2016 | 63 | 0.220 |
Why?
| Sexual Partners | 1 | 2021 | 93 | 0.210 |
Why?
| Choice Behavior | 1 | 2021 | 161 | 0.210 |
Why?
| Proteome | 1 | 2001 | 108 | 0.200 |
Why?
| Adolescent | 10 | 2018 | 9140 | 0.200 |
Why?
| Homosexuality, Female | 1 | 2019 | 17 | 0.200 |
Why?
| Behavior, Addictive | 1 | 2021 | 113 | 0.190 |
Why?
| Receptor, Serotonin, 5-HT1B | 3 | 2003 | 12 | 0.190 |
Why?
| Dopamine Antagonists | 1 | 2018 | 45 | 0.190 |
Why?
| Smoking | 2 | 2012 | 569 | 0.180 |
Why?
| Dopamine | 2 | 2018 | 294 | 0.180 |
Why?
| X Chromosome Inactivation | 1 | 2017 | 29 | 0.180 |
Why?
| Receptors, Thyrotropin | 1 | 2017 | 56 | 0.180 |
Why?
| Chromosomes, Human, Pair 14 | 1 | 2017 | 53 | 0.180 |
Why?
| Risk Factors | 7 | 2021 | 5418 | 0.170 |
Why?
| Body Size | 2 | 2015 | 91 | 0.170 |
Why?
| Chromosomes, Human | 3 | 2009 | 69 | 0.170 |
Why?
| Neurogenesis | 1 | 2018 | 80 | 0.170 |
Why?
| Informed Consent | 1 | 2019 | 243 | 0.170 |
Why?
| Genetic Diseases, Inborn | 1 | 1997 | 99 | 0.170 |
Why?
| DNA | 2 | 2002 | 1305 | 0.170 |
Why?
| Molecular Sequence Annotation | 2 | 2016 | 75 | 0.170 |
Why?
| Nervous System | 1 | 2017 | 81 | 0.170 |
Why?
| Brain Diseases | 1 | 2018 | 188 | 0.170 |
Why?
| Hippocampus | 1 | 2001 | 461 | 0.170 |
Why?
| Prader-Willi Syndrome | 1 | 2016 | 9 | 0.160 |
Why?
| Angelman Syndrome | 1 | 2016 | 8 | 0.160 |
Why?
| Genome | 1 | 2019 | 360 | 0.160 |
Why?
| Models, Genetic | 3 | 2016 | 923 | 0.160 |
Why?
| Fetus | 2 | 2016 | 225 | 0.160 |
Why?
| Statistics as Topic | 1 | 2017 | 243 | 0.160 |
Why?
| Obesity | 3 | 2013 | 966 | 0.160 |
Why?
| Cell Line | 3 | 2018 | 2615 | 0.150 |
Why?
| Educational Status | 1 | 2016 | 173 | 0.150 |
Why?
| Psychiatric Status Rating Scales | 3 | 2012 | 478 | 0.140 |
Why?
| Educational Measurement | 1 | 2016 | 208 | 0.140 |
Why?
| Young Adult | 6 | 2018 | 5970 | 0.140 |
Why?
| Chromosomes, Human, Pair 7 | 2 | 2013 | 87 | 0.140 |
Why?
| Chromosomes, Human, Pair 3 | 2 | 2011 | 58 | 0.140 |
Why?
| Arthritis, Rheumatoid | 1 | 2015 | 156 | 0.140 |
Why?
| Molecular Sequence Data | 7 | 2014 | 3194 | 0.140 |
Why?
| Williams Syndrome | 1 | 2013 | 5 | 0.130 |
Why?
| Autistic Disorder | 2 | 2012 | 138 | 0.130 |
Why?
| Membrane Proteins | 2 | 2017 | 1207 | 0.130 |
Why?
| MicroRNAs | 2 | 2017 | 508 | 0.130 |
Why?
| Hydroxymethylbilane Synthase | 1 | 1993 | 1 | 0.130 |
Why?
| Chromosomes, Human, Pair 16 | 1 | 2013 | 81 | 0.130 |
Why?
| Anthropometry | 1 | 2013 | 79 | 0.130 |
Why?
| Sequence Analysis, DNA | 4 | 2019 | 890 | 0.120 |
Why?
| Amino Acid Substitution | 2 | 2005 | 359 | 0.120 |
Why?
| Tobacco Use Disorder | 1 | 2012 | 87 | 0.110 |
Why?
| Europe | 5 | 2012 | 311 | 0.110 |
Why?
| Aged | 8 | 2018 | 18508 | 0.110 |
Why?
| Gene Expression | 5 | 2010 | 1331 | 0.110 |
Why?
| Receptors, Nicotinic | 1 | 2012 | 131 | 0.110 |
Why?
| Apoptosis | 1 | 2018 | 1775 | 0.110 |
Why?
| Epigenesis, Genetic | 1 | 2015 | 434 | 0.110 |
Why?
| Nerve Tissue Proteins | 2 | 2012 | 529 | 0.110 |
Why?
| Chromosomes, Human, Pair 1 | 2 | 2002 | 103 | 0.110 |
Why?
| Self-Assessment | 1 | 2010 | 47 | 0.110 |
Why?
| Polymorphism, Genetic | 3 | 2004 | 821 | 0.100 |
Why?
| Personality Assessment | 1 | 2010 | 97 | 0.100 |
Why?
| Metabolic Networks and Pathways | 1 | 2010 | 72 | 0.100 |
Why?
| Risk | 3 | 2020 | 700 | 0.100 |
Why?
| Chromosome Deletion | 1 | 2011 | 234 | 0.100 |
Why?
| United States | 5 | 2021 | 6316 | 0.100 |
Why?
| Amino Acid Sequence | 4 | 2002 | 2175 | 0.100 |
Why?
| Gene-Environment Interaction | 3 | 2016 | 101 | 0.100 |
Why?
| Birth Order | 1 | 2009 | 8 | 0.100 |
Why?
| Alcoholism | 1 | 2011 | 181 | 0.100 |
Why?
| Population Surveillance | 1 | 2011 | 241 | 0.100 |
Why?
| Hair | 1 | 2009 | 59 | 0.100 |
Why?
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2008 | 14 | 0.100 |
Why?
| Body Weight | 1 | 2010 | 503 | 0.090 |
Why?
| RNA | 1 | 2013 | 515 | 0.090 |
Why?
| RNA Stability | 2 | 2013 | 90 | 0.090 |
Why?
| Functional Laterality | 1 | 2009 | 203 | 0.090 |
Why?
| Neurons | 1 | 2017 | 1616 | 0.090 |
Why?
| Quality Control | 1 | 2008 | 126 | 0.090 |
Why?
| Kruppel-Like Transcription Factors | 1 | 2008 | 114 | 0.090 |
Why?
| Age of Onset | 4 | 2012 | 320 | 0.090 |
Why?
| Polymorphism, Restriction Fragment Length | 2 | 2001 | 162 | 0.090 |
Why?
| RNA, Messenger | 3 | 2003 | 1996 | 0.080 |
Why?
| Meta-Analysis as Topic | 3 | 2013 | 104 | 0.080 |
Why?
| Cohort Studies | 4 | 2019 | 2710 | 0.080 |
Why?
| Genomics | 2 | 2022 | 648 | 0.080 |
Why?
| Chromosomes, Human, Pair 11 | 1 | 2006 | 108 | 0.080 |
Why?
| Prevalence | 1 | 2010 | 1264 | 0.080 |
Why?
| Thioredoxin Reductase 2 | 1 | 2005 | 3 | 0.080 |
Why?
| Armadillo Domain Proteins | 1 | 2005 | 4 | 0.080 |
Why?
| Thioredoxin-Disulfide Reductase | 1 | 2005 | 5 | 0.080 |
Why?
| Promoter Regions, Genetic | 3 | 2017 | 942 | 0.070 |
Why?
| Databases, Factual | 2 | 2001 | 789 | 0.070 |
Why?
| Pregnancy | 1 | 2012 | 2818 | 0.070 |
Why?
| Waist-Hip Ratio | 2 | 2015 | 22 | 0.070 |
Why?
| Follow-Up Studies | 3 | 2008 | 3877 | 0.070 |
Why?
| Receptors, Dopamine | 1 | 2003 | 44 | 0.060 |
Why?
| Carrier Proteins | 1 | 2007 | 685 | 0.060 |
Why?
| African Americans | 5 | 2012 | 1167 | 0.060 |
Why?
| Nucleic Acid Conformation | 2 | 2003 | 332 | 0.060 |
Why?
| Disease Susceptibility | 3 | 1998 | 183 | 0.060 |
Why?
| Cloning, Molecular | 3 | 1998 | 681 | 0.060 |
Why?
| Signal Transduction | 1 | 2013 | 3301 | 0.060 |
Why?
| Sulfurtransferases | 1 | 2021 | 7 | 0.060 |
Why?
| Cell Cycle Proteins | 1 | 2004 | 387 | 0.060 |
Why?
| Electrophoresis | 1 | 2001 | 60 | 0.060 |
Why?
| Rats, Inbred F344 | 1 | 2021 | 181 | 0.060 |
Why?
| Receptors, Vascular Endothelial Growth Factor | 1 | 2021 | 62 | 0.060 |
Why?
| Problem Solving | 1 | 2021 | 53 | 0.050 |
Why?
| Adoption | 2 | 2011 | 10 | 0.050 |
Why?
| Cell Differentiation | 2 | 2018 | 1474 | 0.050 |
Why?
| Computational Biology | 2 | 2016 | 530 | 0.050 |
Why?
| Brain Chemistry | 1 | 2001 | 122 | 0.050 |
Why?
| Microsatellite Repeats | 4 | 2002 | 145 | 0.050 |
Why?
| Sp4 Transcription Factor | 2 | 2010 | 4 | 0.050 |
Why?
| Suicide, Attempted | 1 | 2021 | 118 | 0.050 |
Why?
| Chromosomes, Human, Pair 21 | 2 | 1997 | 55 | 0.050 |
Why?
| Logistic Models | 3 | 2011 | 1158 | 0.050 |
Why?
| Nuclear Proteins | 1 | 2004 | 697 | 0.050 |
Why?
| DNA, Complementary | 2 | 1997 | 410 | 0.050 |
Why?
| Mutation | 2 | 2003 | 3862 | 0.050 |
Why?
| Aged, 80 and over | 3 | 2018 | 6577 | 0.050 |
Why?
| RNA Editing | 1 | 1998 | 18 | 0.050 |
Why?
| Endothelial Cells | 1 | 2021 | 402 | 0.040 |
Why?
| Enhancer Elements, Genetic | 1 | 2020 | 268 | 0.040 |
Why?
| DNA Footprinting | 1 | 2017 | 18 | 0.040 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2011 | 702 | 0.040 |
Why?
| Receptors, LDL | 1 | 1998 | 67 | 0.040 |
Why?
| Phosphoric Monoester Hydrolases | 1 | 1997 | 48 | 0.040 |
Why?
| Quantitative Trait, Heritable | 1 | 2018 | 125 | 0.040 |
Why?
| Deoxyribonucleases, Type II Site-Specific | 2 | 1996 | 32 | 0.040 |
Why?
| Genes | 1 | 1998 | 319 | 0.040 |
Why?
| Multigene Family | 1 | 1997 | 215 | 0.040 |
Why?
| Dendrites | 1 | 2017 | 104 | 0.040 |
Why?
| Gene Library | 1 | 1997 | 130 | 0.040 |
Why?
| Oligodeoxyribonucleotides | 1 | 1997 | 129 | 0.040 |
Why?
| Chromosome Duplication | 1 | 2016 | 10 | 0.040 |
Why?
| Receptors, Dopamine D2 | 1 | 1996 | 64 | 0.040 |
Why?
| Genomic Imprinting | 1 | 2016 | 34 | 0.040 |
Why?
| Animals | 4 | 2021 | 26985 | 0.040 |
Why?
| Neuregulin-1 | 2 | 2006 | 15 | 0.040 |
Why?
| Chromosomes, Human, Pair 10 | 2 | 2008 | 48 | 0.040 |
Why?
| Synapses | 1 | 2017 | 332 | 0.030 |
Why?
| Genes, Reporter | 1 | 2014 | 268 | 0.030 |
Why?
| Evolution, Molecular | 1 | 2001 | 833 | 0.030 |
Why?
| Nuclear Family | 3 | 2000 | 91 | 0.030 |
Why?
| Polymerase Chain Reaction | 2 | 1996 | 999 | 0.030 |
Why?
| Rats | 1 | 2021 | 4351 | 0.030 |
Why?
| Sweden | 1 | 2013 | 44 | 0.030 |
Why?
| Alzheimer Disease | 1 | 2016 | 335 | 0.030 |
Why?
| Genetic Heterogeneity | 1 | 2013 | 60 | 0.030 |
Why?
| Child Development Disorders, Pervasive | 1 | 2013 | 38 | 0.030 |
Why?
| Inheritance Patterns | 1 | 2013 | 52 | 0.030 |
Why?
| Base Composition | 1 | 2013 | 34 | 0.030 |
Why?
| HapMap Project | 1 | 2013 | 48 | 0.030 |
Why?
| Half-Life | 1 | 2013 | 108 | 0.030 |
Why?
| Protein Binding | 1 | 2017 | 1509 | 0.030 |
Why?
| Codon, Nonsense | 1 | 2013 | 42 | 0.030 |
Why?
| Adolescent Development | 1 | 2012 | 17 | 0.030 |
Why?
| Factor Analysis, Statistical | 1 | 2012 | 104 | 0.030 |
Why?
| Transcription, Genetic | 1 | 1998 | 1167 | 0.030 |
Why?
| Cell Proliferation | 1 | 2018 | 1613 | 0.030 |
Why?
| Computer Simulation | 1 | 2016 | 1059 | 0.030 |
Why?
| Cognition | 1 | 2016 | 500 | 0.030 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2013 | 182 | 0.030 |
Why?
| Genes, Recessive | 2 | 2002 | 88 | 0.030 |
Why?
| Twin Studies as Topic | 1 | 2011 | 20 | 0.030 |
Why?
| Genetic Pleiotropy | 1 | 2011 | 23 | 0.030 |
Why?
| Cross-Sectional Studies | 1 | 2015 | 1434 | 0.030 |
Why?
| Genetic Association Studies | 1 | 2012 | 291 | 0.030 |
Why?
| Random Allocation | 1 | 2011 | 376 | 0.030 |
Why?
| Age Factors | 1 | 2015 | 1916 | 0.030 |
Why?
| Analysis of Variance | 1 | 2013 | 962 | 0.030 |
Why?
| Vacuolar Proton-Translocating ATPases | 1 | 2009 | 17 | 0.030 |
Why?
| Odds Ratio | 1 | 2012 | 683 | 0.030 |
Why?
| Twins | 1 | 2010 | 65 | 0.030 |
Why?
| Microarray Analysis | 1 | 2010 | 103 | 0.030 |
Why?
| Lung Diseases | 1 | 2012 | 268 | 0.030 |
Why?
| Longitudinal Studies | 1 | 2013 | 988 | 0.030 |
Why?
| Receptors, Metabotropic Glutamate | 1 | 2009 | 68 | 0.020 |
Why?
| Principal Component Analysis | 1 | 2009 | 153 | 0.020 |
Why?
| Major Histocompatibility Complex | 1 | 2009 | 92 | 0.020 |
Why?
| Transcription Factors | 1 | 2017 | 1517 | 0.020 |
Why?
| Statistics, Nonparametric | 2 | 2000 | 325 | 0.020 |
Why?
| Genetics, Population | 1 | 2012 | 378 | 0.020 |
Why?
| Cell Line, Tumor | 1 | 2014 | 2426 | 0.020 |
Why?
| Environment | 1 | 2010 | 219 | 0.020 |
Why?
| Algorithms | 1 | 2016 | 1847 | 0.020 |
Why?
| Dystrophin-Associated Proteins | 1 | 2007 | 4 | 0.020 |
Why?
| Crohn Disease | 1 | 2013 | 721 | 0.020 |
Why?
| Recurrence | 1 | 2010 | 1196 | 0.020 |
Why?
| Severity of Illness Index | 1 | 2012 | 1778 | 0.020 |
Why?
| Sex Factors | 1 | 2010 | 1090 | 0.020 |
Why?
| 5' Untranslated Regions | 1 | 2003 | 46 | 0.020 |
Why?
| Transcription Factor AP-1 | 1 | 2003 | 66 | 0.020 |
Why?
| CHO Cells | 1 | 2003 | 198 | 0.020 |
Why?
| Receptors, G-Protein-Coupled | 1 | 2004 | 126 | 0.020 |
Why?
| Oligonucleotides | 1 | 2003 | 97 | 0.020 |
Why?
| Databases, Genetic | 1 | 2004 | 262 | 0.020 |
Why?
| Cricetinae | 1 | 2003 | 577 | 0.020 |
Why?
| DNA Mutational Analysis | 1 | 2004 | 538 | 0.020 |
Why?
| Transcriptional Activation | 1 | 2003 | 287 | 0.020 |
Why?
| Africa | 1 | 2002 | 100 | 0.010 |
Why?
| Australia | 1 | 2002 | 90 | 0.010 |
Why?
| Child | 1 | 2013 | 6768 | 0.010 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 924 | 0.010 |
Why?
| Canada | 1 | 2002 | 205 | 0.010 |
Why?
| Family Health | 1 | 2001 | 166 | 0.010 |
Why?
| Matched-Pair Analysis | 1 | 2000 | 45 | 0.010 |
Why?
| Infant | 2 | 1998 | 3103 | 0.010 |
Why?
| Protein Biosynthesis | 1 | 2003 | 379 | 0.010 |
Why?
| Genes, Dominant | 1 | 2000 | 120 | 0.010 |
Why?
| Databases as Topic | 1 | 2000 | 94 | 0.010 |
Why?
| Chromosomes, Human, Pair 5 | 1 | 2000 | 109 | 0.010 |
Why?
| Up-Regulation | 1 | 2003 | 712 | 0.010 |
Why?
| Lung Neoplasms | 1 | 2012 | 2119 | 0.010 |
Why?
| Sequence Tagged Sites | 1 | 1997 | 12 | 0.010 |
Why?
| Chromosomes, Artificial, Yeast | 1 | 1997 | 36 | 0.010 |
Why?
| National Institute of Mental Health (U.S.) | 1 | 1997 | 22 | 0.010 |
Why?
| Chromosomes, Human, Pair 20 | 1 | 1997 | 35 | 0.010 |
Why?
| Chromosomes, Human, Pair 4 | 1 | 1997 | 49 | 0.010 |
Why?
| Hybrid Cells | 1 | 1997 | 89 | 0.010 |
Why?
| Deoxyribonuclease EcoRI | 1 | 1997 | 7 | 0.010 |
Why?
| Chromosomes, Human, Pair 19 | 1 | 1997 | 60 | 0.010 |
Why?
| Chromosomes, Human, Pair 9 | 1 | 1997 | 91 | 0.010 |
Why?
| Receptors, Dopamine D3 | 1 | 1996 | 17 | 0.010 |
Why?
| Introns | 1 | 1998 | 282 | 0.010 |
Why?
| Alternative Splicing | 1 | 1998 | 191 | 0.010 |
Why?
| Likelihood Functions | 1 | 1997 | 259 | 0.010 |
Why?
| Homozygote | 1 | 1996 | 209 | 0.010 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 1996 | 138 | 0.010 |
Why?
| Exons | 1 | 1998 | 461 | 0.010 |
Why?
| Protein Structure, Tertiary | 1 | 1998 | 766 | 0.010 |
Why?
| Heterozygote | 1 | 1996 | 374 | 0.010 |
Why?
| Models, Statistical | 1 | 1999 | 580 | 0.010 |
Why?
| Risk Assessment | 1 | 1996 | 2284 | 0.010 |
Why?
|
|
Sanders's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|